Berita

From Sequence to Patient in Under 12 Months: A Case Stu...

In this GEN webinar, Joseph Shultz (VP of technical development and manufacturin...

Macrophages Use Cell Volume Changes to Sense Danger and...

Macrophages use shifts in cell volume as a danger‑sensing cue that rewires gene ...

Cellular Origins Collaborates with Immatics on Automati...

The collaboration taking place between Cellular Origins and Immatics will explor...

Digital PCR Playbook: Applications and Challenges Acros...

In this GEN The post Digital PCR Playbook: Applications and Challenges Across Re...

Oral Small-Molecule GLP-1s Linked to Deep Brain Activit...

New findings in mice suggest that oral small-molecule GLP-1 drugs may directly i...

Human Antibodies Identified That Have Potential To Prev...

Scientists identified human mAbs from a previously measles-vaccinated human, whi...

When a “Weird Spot” is Worth Getting Checked

How to Identify Skin Cancer Signs and Stay on Top of Your Skin Health Noticing a...

What’s next for IVF

MIT Technology Review’s What’s Next series looks across industries, trends, and ...

Bayer to Acquire Perfuse for Up to $2.45B, Seeing Ophth...

Bayer’s ophthalmology pipeline has long been dominated by the blockbuster drug E...

Next Gen Leadership Awards Presented at the AGBT Agricu...

The AGBT Agricultural Meeting was held last month in Phoenix, Arizona. During th...

USMLE Step 1 Mnemonics: Master Your Study Techniques

From the perspective of a med student-turned-tutor who has used them in the tren...

Bayer to Acquire Perfuse for up to $2.45B, Seeing Ophth...

Bayer’s ophthalmology pipeline has long been dominated by the blockbuster drug E...

Microproteins and Peptideins Expand Boundaries of the H...

Researchers have discovered 1,700 new proteins in what’s known as the "dark prot...

From Discovery to GMP: Building Scalable Cell Therapy M...

This eBook brings together perspectives from Genetic Engineering News and Elevat...

UCB to Acquire Candid for Up to $2.2B, Expanding Presen...

UCB said its planned acquisition of Candid, plus an earlier licensing deal with ...

Light-Controlled Gene Expression Platform Reportedly Do...

The real opportunity lies in next generation complex biologics such as multispec...